Cardiovascular diseases (CVDs) have become a significant health concern in India, leading to a high incidence rate of mortality and disability. According to the World Health Organization (WHO), the death rate for CVDs in India is 272 per one lakh population, which is higher than the global average of 235. In recent years, the prevalence of CVDs in India has increased rapidly due to lifestyle changes and risk factors such as hypertension, diabetes mellitus, dyslipidemia, physical inactivity, diet, and addiction.
Cardiovascular diseases (CVDs) are a significant cause of mortality worldwide. In India, CVDs account for 28 percent of all deaths, with ischemic heart disease and stroke being the two most common causes. To combat this rising issue, the medical industry has emphasized the need for technology-driven investigative and therapeutic modalities, including imaging, cath lab, angiographic radiographic tools, contrast agents, and electronically implanted cardiovascular devices. Cardiovascular devices have become instrumental in diagnosing and managing arrhythmia, heart failure, coronary artery disease, valvular heart disease, and other heart conditions. With increasing economic status and a growing focus on healthcare, there has been a significant rise in the adoption levels of advanced cardiovascular devices, promoting medical tourism.
India has a higher mortality rate due to CVDs in the 40-69 year age group, and the incidence of the disease is spreading like a mini-pandemic. Diagnostic tools such as Electrocardiogram machines, Echocardiography (USG), Holter monitoring, X-ray, CT, and MRI are used to diagnose and treat major cardiovascular conditions and improve the quality of life. USG devices, such as 2D echo, are used to analyze cardiac functions and detect structural cardiac abnormalities.
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 2023 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Granules' Visakhapatnam - Unit V facility passes FDA inspection
Granules India's Unit V facility in Visakhapatnam has completed US FDA inspection with zero 483 observations.
Mankind to set up 'Digital Smart Classrooms' in villages
Under the project, Mankind Pharma to equip 220 government schools from Uttar Pradesh, Himachal Pradesh, and Uttarakhand with learning tools and technology.
Indegene acquires medical writing player from Germany
Indegene acquires Trilogy Writing & Consulting GmbH, enhancing medical writing capabilities for life sciences companies.
Medulance bags 25.06 cr series-A VC funding
Latest VC funding to be invested in expanding emergency healthcare in India.
HUMAN TOUCH IN HEALTHCARE
Healthcare must prioritize empathy, not efficiency, for better patient experience, moving from cost center to core strategy, argues author
SMART BANDAGES A REVOLUTION IN WOUND CARE
Wound care is about to get a technological upgrade! See how next-generation intelligent dressings may help to fight infections and assist in the fast healing of wounds
THE EMERGING THREAT OF LUPUS
Explore the prevalence and growth rates of Lupus in India and ways to tackle this emerging healthcare challenge.
INDIA'S NURSES' SHORTAGE: FINDING CURE
The acute scarcity of nurses is burdening India's healthcare system, risking patient care outcomes. Explore the way forward.
New guidelines to address fluid management in hospitalized patients
API and Kenvue India release guidelines for managing oral fluids, electrolytes, and energy in non-diarrheal patients for hospitals in India.
HealthTech hiring stays strong despite funding slowdown - Report
India's HealthTech hiring demonstrates resilience with employment surging by nine percent amidst a funding deceleration.
